Challenges of rapid reviews for diagnostic test accuracy questions: a protocol for an international survey and expert consultation. by Arevalo-Rodriguez, Ingrid et al.
PROTOCOL Open Access
Challenges of rapid reviews for diagnostic
test accuracy questions: a protocol for an
international survey and expert
consultation
Ingrid Arevalo-Rodriguez1* , Andrea C. Tricco2,3, Karen R. Steingart4, Barbara Nussbaumer-Streit5, David Kaunelis6,
Pablo Alonso-Coello7,8, Susan Baxter9, Patrick M. Bossuyt10 and Javier Zamora1
Abstract
Background: Assessment of diagnostic tests, broadly defined as any element that aids in the collection of
additional information for further clarification of a patient’s health status, has increasingly become a critical issue in
health policy and decision-making. Diagnostic evidence, including the accuracy of a medical test for a target
condition, is commonly appraised using standard systematic review methodology. Owing to the considerable time
and resources required to conduct these, rapid reviews have emerged as a pragmatic alternative by tailoring
methods according to the decision maker’s circumstances. However, it is not known if streamlining methodological
aspects has an impact on the validity of evidence synthesis. Furthermore, due to the particular nature and
complexity of the appraisal of diagnostic accuracy, there is need for detailed guidance on how to conduct rapid
reviews of diagnostic tests. In this study, we aim to identify the methods currently used by rapid review developers
to synthesize evidence on diagnostic test accuracy, as well as to analyze potential shortcomings and challenges
related to these methods.
Methods: We will carry out a two-fold approach: (1) an international survey of professionals working in
organizations that develop rapid reviews of diagnostic tests, in terms of the methods and resources used by these
agencies when conducting rapid reviews, and (2) semi-structured interviews with senior-level individuals to further
explore and validate the findings from the survey and to identify challenges in conducting rapid reviews. We will
use STATA 15.0 for quantitative analyses and framework analysis for qualitative analyses. We will ensure protection
of data during all stages.
Discussion: The main result of this research will be a map of methods and resources currently used for conducting
rapid reviews of diagnostic test accuracy, as well as methodological shortcomings and potential solutions in
diagnostic knowledge synthesis that require further research.
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Introduction
Assessment of diagnostic tools, broadly defined as any
element that aids in the collection of additional informa-
tion for further clarification of the current status of a pa-
tient’s health [1], has emerged as a critical issue in health
policy and global decision-making [2]. This rise has been
mostly driven by the rapid technological developments
of recent years, as well as a demand for the earlier iden-
tification of deleterious conditions, among other factors
[2, 3]. Diagnostic evidence, including estimation of the
accuracy of a test for detecting a target condition, in
addition to comparing the accuracy of several tests, can
be appraised using systematic reviews that follow rigor-
ous methods [4–6]. In general, diagnostic accuracy stud-
ies focus on estimating the ability of the test(s) to
correctly identify subjects with a predefined target con-
dition, or the condition of interest (sensitivity) as well as
to clearly identify those without the condition (specifi-
city) [5].
Systematic reviews are currently the most widely used
for searching, assessing and synthesising healthcare evi-
dence [7]. However, the development of standard sys-
tematic reviews requires considerable time and
resources, which may not be available in critical
decision-making/time-sensitive scenarios [8, 9]. Recently,
Beese et al. estimated that the probability of completing
a Cochrane diagnostic test accuracy (DTA) review in 2
years was less than 10%, increasing to 33% in 4 years and
to 58% in 8 years [10]. For intervention issues, rapid re-
views have emerged as a pragmatic alternative to con-
ventional systematic reviews by tailoring the methods
according to the decision maker’s circumstances [4, 11–
13]. Although a commonly accepted definition for rapid
reviews does not yet exist in the literature, we define a
rapid review as a knowledge synthesis strategy using lim-
ited or accelerated methods to expedite the time re-
quired to obtain a conclusive answer [11, 14]. Systematic
review stages such as framing of the scope, literature
searches and selection of eligible studies have been con-
sidered as key areas to improve the production time
[14]. In addition, as a demand-driven product requested
by end-users, rapid reviews are developed in a limited
amount of time and with limited resources [15].
Despite the apparent advantages of rapid reviews,
questions remain regarding the reliability of their con-
clusions in decision-making scenarios [16]. Recently,
Marshall et al. assessed the impact of selected rapid re-
view methods on the estimation of effect measures, con-
cluding that rapid review approaches can be insufficient
in scenarios where high precision is needed in the nu-
merical estimation of the effect [17]. In addition, similar
to conventional/aggregated data systematic reviews,
there are some circumstances where rapid reviews can
fail to provide answers to specific issues (such as
subgroups of patients, or to analyze the influence of crit-
ical characteristics of the assessed test), and approaches
such as individual-patient data analyses would be highly
recommended [18–20].
An adequate level of comparative diagnostic accuracy
is necessary to ensure a positive impact on final out-
comes [21]. Due to the particular nature and complexity
of the assessment of diagnostic accuracy, including the
role and purpose of the test (e.g. screening or diagnosis),
the setting of application, the identification/search for
evidence, and the type of numerical information pro-
vided (i.e. sensitivity and specificity estimates), detailed
guidance on how to conduct rapid reviews that address
DTA questions is required. At present, few studies have
addressed the impact of methodological shortcuts in
diagnostic synthesis [22] and further information regard-
ing the strategies currently in use is urgently needed [2,
23, 24].
This study belongs to a research series on the develop-
ment of rapid reviews in diagnostic knowledge synthesis
(further information is available at the Open Science
Framework website: https://osf.io/uj7mc/?view_on-
ly=32189f1e47ce489482546a059a38a947). In this study,
we will focus on identifying the current methods used
by organizations that produce rapid reviews of diagnos-
tic test. We will also explore the potential challenges
and discuss the implications for further research.
Methods
We will carry out a two-fold approach that includes an
international survey of organizations developing diag-
nostic knowledge synthesis, and individual interviews
with experts to identify shortcomings and challenges of
the methodology used, as well as to suggest potential so-
lutions for the future.
International survey
We will carry out an international survey of current
methods used by agencies that produce rapid reviews,
based on a previous survey of rapid review developers
[9]. In particular, we will contact current International
Network of Agencies for Health Technology Assessment
(INAHTA) members, the World Health Organization
(WHO) collaborating centres on Health Technology As-
sessment (HTA), the Health Technology Assessment
Network of the Americas (REDETSA) and the Health
Technology Assessment International (HTAi) network
non-profit members.
In order to obtain information on the methods and re-
sources used by these agencies, we will develop an on-
line questionnaire containing information about
activities, methods and resources organized by review
development stages [25]. The online survey will include
the following issues:
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1. General issues for the development of rapid reviews
of diagnostic tests (including time for development,
intended audience, commissioner of these reviews,
focus of diagnostic reviews).
2. Composition of the review team for conducting of
rapid reviews of diagnostic tests.
3. Methodological shortcuts used (including
abbreviated search strategies, number of authors
involved in the screening, selection of references
and collection of data).
4. Methods for performing the synthesis of study
results (including use of the GRADE system).
5. Issues regarding the preparation of the review
report and their ending.
A pilot assessment of the survey will be performed by
five external experts in conducting reviews and rapid re-
views to ensure feasibility, duration and understandabil-
ity. The final online survey, after feedback derived from
the pilot assessment, will be conducted using Survey-
Monkey (https://surveymonkey.com/). Participants will
be invited via personalized emails, including a link to the
online survey and a formal invitation letter. Regular re-
minders will be sent to increase the response rate.
After completion, data will be downloaded from the
online platform to an Excel file and analyzed using
STATA 15.0 (https://www.stata.com/). We will include
all information retrieved, including incomplete surveys
and we will adhere to CHERRIES guidance to report our
survey findings [26].
Semi-structured interview
Qualitative interviews will be used to further explore
and validate the findings from the survey and to con-
sider what is needed to address any potential challenges
identified. We will use a purposeful sampling [27] to
identify senior-level individuals and topic experts from
relevant organizations in the field. We will seek individ-
uals from different types of organizations and with dif-
ferent characteristics that may be important (e.g. years
of experience, role) to ensure diversity of viewpoints.
We expect that a sample of 10–12 individuals will give
sufficient variation and enable data saturation to be
achieved [28].
Semi-structured interviews will be carried out via
GoToMeeting (https://www.gotomeeting.com/es-es). We
will develop an interview guide that will take into con-
sideration the results of the survey. Topics will include
the following:
1. The validity of methods and resources employed by
agencies and participants of the survey
2. The completeness of the essential list of methods
and resources, reported by the survey participants
3. The challenges faced in conducting valid, accurate
and useful rapid reviews of diagnostic tests in the
future
4. Potential solutions to the critical challenges
identified
A member of the research team will transcribe the in-
terviews after data collection, and original recordings
will be stored in a secure online data depository. During
transcription, all identifying information will be removed
to preserve anonymity and confidentiality of partici-
pants. A framework analysis approach will be used to
examine the data. The initial framework will be based on
the survey structure and results, with subsequent revi-
sions and additions to develop a set of topics and
sub-topics [29]. The initial analysis will be led by one re-
searcher, with other members of the research team con-
tributing to the development of the final framework.
Atlas Ti software (https://atlasti.com/) will be used to
aid systematic storage and retrieval of data during ana-
lysis, after which recordings and transcripts will be
deleted.
Ethical considerations and data protection
We will follow the Declaration of Helsinki ethical princi-
ples for the treatment of human participants, including
ensuring informed consent prior to data collection,
avoidance of coercion in recruitment, and preservation
of confidentiality and anonymity [30]. Survey partici-
pants in the first element of the study will be given in-
formation about the study prior to commencing the
survey and will be asked to acknowledge that they con-
sent to take part. During the analysis, all identifying in-
formation will be removed to preserve anonymity and
confidentiality of participants. Interview participants will
be provided with an information sheet prior to taking
part and asked to verbally agree to participate, which
will be included in the recording. The interviews will
take place at a convenient time for participants, and re-
quests to stop recording for short periods during the
interview will be allowed. All data relating to this study
will be held in a secure repository for 5 years after the
study has finished.
Discussion
As the main result of this research, we will have an ex-
tensive map of methods and resources currently used for
conducting DTA rapid reviews, as well as methodo-
logical shortcomings and potential solutions identified
by experts in diagnostic knowledge synthesis, that re-
quire further research. We anticipate the following
strengths and limitations of our study:
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Strengths
As the main strength of our research, we will combine
two different methodologies to obtain a comprehensive
overview of rapid review methods used for synthesis of
DTA evidence. In addition, we will analyse the methodo-
logical challenges in this field, provided by experts in
diagnostic evidence, in order to identify further research
needed for the development of diagnostic evidence
synthesis.
Limitations
Currently, a commonly-accepted definition for rapid re-
views does not exist. As such, there will be variation in
the responses of participants in our study. To reduce the
potential heterogeneity derived from this issue, we will
provide a definition of rapid review in our study.
Likewise, our research might be limited to the rate of
response of our survey by agencies producing DTA rapid
reviews. We will send personalized emails to key individ-
uals in each agency to ensure their participation. In
addition, we will send regular reminders to increase the
survey response rate. We will have an extended period
to collect all potential responses from eligible partici-
pants. Analysis of survey findings will also depend on
the profile of experts selected for semi-structured inter-
views. We will develop a list of critical characteristics in
advance to ensure the diversity of viewpoints in this
analysis.
Finally, we also expected that our findings will be ap-
plicable to diagnostic questions regarding the accuracy
of a single test, as well as to the assessment of compara-
tive accuracy of tests in a specific setting. However, spe-
cial synthesis of test accuracy issues, such as incremental
accuracy assessment, synthesis of predictive values or
sensitivity only, are outside of the scope of our research.
Further research
This study belongs to a research series on the develop-
ment of rapid reviews in diagnostic knowledge synthesis.
The findings of this study will be the initial step for fur-
ther research on conducting DTA rapid reviews.
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